Philip Tønnesen (Glostrup, Denmark), Luke J. Clancy (Dublin, Ireland)
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice
Constantinos Glynos (Athens, Greece), Constantinos Glynos, Sofia-Irida Bibli, Athanasia Pavlidou, Paraskevi Katsaounou, Ioannis Kalomenidis, Spyros Zakynthinos, Andreas Papapetropoulos
|    |
Assessment of throat-hit and desire to switch from tobacco to e-cigarette during blind test of e-liquid and e-cigarette
Bertrand Dautzenberg (Paris, France), Bertrand Dautzenberg, Aledandre Scheck, Celine Kayal, Marie-Dominique Dautzenberg
| |
Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community?
Elif Dagli (Istanbul, Turkey), Elif Dagli
| |
Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece
Paraskevi Katsaounou (Athens, Greece), Paraskevi Katsaounou, Aikaterini Bilitou, Vasilis Tsekouras
| |
Efficacy of varenicline among smokers enrolled on a public health tobacco control program (HM-TCP) in the real-life setting
Maria da Penha Uchoa Sales (Fortaleza, Brazil), Maria da Penha Sales, Fernando Aguiar, Maria Irenilza Oliveira
| |
Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Heikki Ekroos (Kerava, Finland), Heikki Ekroos, Kirsi Kautiainen, Mikko Puhakka, Helena Liira, Juha Laine, Kari Linden, Jarmo Hahl
| |